NewzModerna shares surged by nearly 88 percent on Wall Street following the release of positive test results for a new skin cancer vaccine. According to the company's research, the experimental vaccine reduces the likelihood of the cancer returning or spreading.
The announcement drove significant market activity for the American biotechnology firm, highlighting investor optimism regarding advancements in the development of targeted cancer immunotherapies.
In-depth summary · AI, neutral